Skip to main content
NewslettersWatchlist

Carlisle Companies Inc(CSL-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low399.87
Day High415.00
Open:410.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Stocks Rebound on a Dovish US ISM Services Report
Barchart
Stocks Waver on Higher Bond Yields Ahead of Fed Chair Powell
Barchart
Chart of the Day: Carlisle Keeps Building
Newswire.ca
Health Canada Authorizes CSL's HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B
PR Newswire
New Data Presented at IDWeek 2023 Demonstrates Public Health Benefit and Cost Savings Associated with Cell-Based and Adjuvanted Influenza Vaccines
PR Newswire
CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems
PR Newswire
CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine
PR Newswire
CSL Appoints Jeffrey Ball as First Chief Sustainability Officer
PR Newswire
CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season
Motley Fool
4 Industrial Stocks That Are Screaming Buys in June
Business Wire
Carlisle Companies Declares Regular Quarterly Dividend
Business Wire
Carlisle Companies Elects C. David Myers to its Board of Directors
Business Wire
Carlisle Companies Announces May 2023 Events with the Financial Community
Business Wire
Carlisle Companies Reports First Quarter Results
Motley Fool
3 Stocks You Can Keep Forever
Business Wire
Carlisle Companies to Announce First Quarter 2023 Results on April 27, 2023
Business Wire
Carlisle Companies Announces March 2023 Events with the Financial Community
MarketBeat
These 11 stocks will be Dividend Kings in 5 years or less.
PR Newswire
First Gene Therapy for Hemophilia B, CSL's HEMGENIX®, Approved by the European Commission
Business Wire
Carlisle Companies Reports Record Fourth Quarter and Full Year 2022 Results
Business Wire
Carlisle Companies Declares Regular Quarterly Dividend
Business Wire
Carlisle Companies to Announce Fourth Quarter 2022 Results on February 7, 2023
Business Wire
Carlisle Companies Announces Commitment to Achieve Net-Zero GHG Emissions by 2050
PR Newswire
CSL's Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B at 24-Months Post-Treatment
MarketBeat
Why CSL Ltd Stock Could Be Worth a Look
Business Wire
Henry, a Carlisle Company, Recognized as The Home Depot’s Building Materials Vendor of the Year
Business Wire
Carlisle Companies Declares Regular Quarterly Dividend
Business Wire
Carlisle Companies to Present at Baird Industrial Conference on November 9
Business Wire
Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
Business Wire
Carlisle Companies Reports Record Third Quarter Results
Business Wire
Carlisle Companies Issues Broad-Based Equity Grant to Employees
Motley Fool
3 Stocks to Add to Your Portfolio in the Market Downturn

Profile

Carlisle Companies Incorporated is a diversified, global portfolio of niche brands and businesses with highly engineered and high margin products. It engages in the design, manufacture and sale of a wide range of roofing and waterproofing products, engineered products and finishing equipment. The company sells its products in the United States, Europe, Asia, Canada, Mexico, Latin America, the Middle East and Africa.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.